share_log

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

Benzinga ·  Mar 21 11:28

HC Wainwright & Co. analyst Edward White reiterates InflaRx (NASDAQ:IFRX) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 342
Write a comment